AstraZeneca Invites You to the Beijing Smart Healthcare Technology Innovation Forum with Concurrent Call for Roadshow Projects

The Beijing Smart Healthcare Technology Innovation Forum, hosted by AstraZeneca and organized by the Beijing International Life Science Innovation Park (Beijing iCampus), will kick off on December 15. Themed “Unite Without Boundaries, Advance to New Horizons,” the forum will bring together government leaders, authoritative experts, industry-leading enterprises, and professional investors from the healthcare sector both in China and abroad for online discussions. Through forward-looking, authoritative, and predictive dialogues, along with professional evaluations of pitching companies, the event aims to identify high-quality innovative collaboration projects, promote the integration of the medical industry chain tailored to local conditions, and elevate the establishment and development of Beijing’s smart healthcare ecosystem to a new level.

Scan the QR code to register for the conference.

The Beijing Smart Healthcare Technology Innovation Forum is another key component of AstraZeneca’s series of ecosystem conferences. Leveraging its extensive resources and platform advantages, AstraZeneca has continuously expanded its innovation ecosystem and achieved significant progress. The company has successfully hosted multiple high-profile ecosystem events, including the 5th AstraZeneca China Ecosystem Conference and the Western China Smart Healthcare Industry Summit. By building platforms that facilitate integration between industry and finance, AstraZeneca has fostered broader cross-sector collaboration, effectively driving the high-quality development of the life and health industry.

As a leading multinational pharmaceutical company in China’s healthcare industry, AstraZeneca introduced the concept of an innovative health ecosystem many years ago and has since collaborated with local governments to jointly establish international life science innovation parks (iCampus) in Wuxi, Beijing, Hangzhou, Chengdu, Shanghai, Yixing, Guangzhou, and Qingdao, integrating regional characteristics and industrial features.

iCampus is also China’s first global innovation incubation industrial park developed under a public-private partnership model. Leveraging local advantages such as concentrated resource allocation and policy support, while drawing on AstraZeneca’s innovation strategy, regional ecosystem strengths, and global network, iCampus has facilitated both “bringing in” and “going global.” It introduces cutting-edge, high-potential foreign innovative enterprises into the Chinese market and propels domestic innovators onto the world stage through AstraZeneca’s global network.

At this forum,Academician Wang Chen, Academician of the Chinese Academy of Engineering, Member of the Faculty of the Chinese Academy of Medical Sciences, and President of the Chinese Academy of Medical Sciences; Professor Chi Chunhua, Director of the Department of General Practice at Peking University First Hospital; Dean Wu Hao, School of General Practice and Continuing Education, Capital Medical University; Professor Zhao Dong, Luhe Hospital in Tongzhou District, BeijingDistinguished experts will personally share with you the technical application scenarios and successful practices in China’s smart healthcare sector.

Meanwhile, the forum also invited guests fromThe United Kingdom, Israel, Canada, and Australiaas an innovative partner, bringing global trends and advanced experience in smart healthcare to overseas markets, and will continue to integrate cutting-edge international innovation to inject new energy into the development of China’s smart healthcare sector.

The forum also took this opportunity to organize a"Technology Empowers Smart Healthcare"a themed roundtable discussion, presenting a feast of insights from diverse perspectives, including industry investors, healthcare media, cutting-edge innovative enterprises, and AstraZeneca.

Meanwhile, the forum has also established a platform for face-to-face in-depth exchanges with investors to facilitate incubation, specifically recruiting the following innovative projects to participate in roadshow matchmaking:

around"Respiration"and"Metabolism"Pharmaceuticals, medical devices, and foods for special medical purposes required for the screening, diagnosis, treatment, and rehabilitation of diseases; as well as innovative diagnostic and therapeutic models that leverage technologies such as the Internet, Internet of Things (IoT), and artificial intelligence to serve the entire process of prevention, screening, diagnosis, treatment, and health management for two categories of diseases throughout the patient’s full life cycle, including digital therapeutics.

There will be on-siteAstraZenecaCICC Healthcare Industry Fund, Northern Light Venture Capital, Shunwei Capital, Legend Star, Boying Capital, Kaifeng Ventures, China Merchants Health, Yusen CapitalRenowned investment firms and industry veterans provided expert commentary on the companies and projects participating in the roadshow, offering high-value guidance on development pathways to help enterprises further expand their visibility and foster greater possibilities for innovative collaboration and project incubation.

Hereby, the forum sincerely invites all companies interested in the roadshow to scan and register, joining us in this strategic dialogue on the future of smart healthcare!

Scan the QR code to submit your roadshow information; our staff will contact you within one week.

New-generation information technologies, represented by big data, the Internet of Things (IoT), and artificial intelligence (AI), have deeply penetrated the healthcare industry and are poised to lead its future development.

If you also wish to join the new future of smart healthcare in China

December 15 “Beijing Smart Healthcare Technology Innovation Forum”

Meet in the cloud—be there or be square!